Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 574

1.

Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.

Couturaud F, Julian JA, Kearon C.

Thromb Haemost. 2001 Oct;86(4):980-4.

PMID:
11686355
[PubMed - indexed for MEDLINE]
2.

Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.

Merli G, Spiro TE, Olsson CG, Abildgaard U, Davidson BL, Eldor A, Elias D, Grigg A, Musset D, Rodgers GM, Trowbridge AA, Yusen RD, Zawilska K; Enoxaparin Clinical Trial Group.

Ann Intern Med. 2001 Feb 6;134(3):191-202.

PMID:
11177331
[PubMed - indexed for MEDLINE]
3.

Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials.

Quinlan DJ, McQuillan A, Eikelboom JW.

Ann Intern Med. 2004 Feb 3;140(3):175-83.

PMID:
14757615
[PubMed - indexed for MEDLINE]
4.

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.

Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM.

Ann Intern Med. 1999 May 18;130(10):800-9.

PMID:
10366369
[PubMed - indexed for MEDLINE]
5.

Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.

Kearon C, Ginsberg JS, Julian JA, Douketis J, Solymoss S, Ockelford P, Jackson S, Turpie AG, MacKinnon B, Hirsh J, Gent M; Fixed-Dose Heparin (FIDO) Investigators.

JAMA. 2006 Aug 23;296(8):935-42.

PMID:
16926353
[PubMed - indexed for MEDLINE]
6.

Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.

Breddin HK, Hach-Wunderle V, Nakov R, Kakkar VV; CORTES Investigators. Clivarin: Assessment of Regression of Thrombosis, Efficacy, and Safety.

N Engl J Med. 2001 Mar 1;344(9):626-31.

PMID:
11228276
[PubMed - indexed for MEDLINE]
Free Article
7.
8.

Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism.

Hettiarachchi RJ, Prins MH, Lensing AW, Buller HR.

Curr Opin Pulm Med. 1998 Jul;4(4):220-5.

PMID:
10813237
[PubMed - indexed for MEDLINE]
9.

Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis.

Mismetti P, Quenet S, Levine M, Merli G, Decousus H, Derobert E, Laporte S.

Chest. 2005 Oct;128(4):2203-10.

PMID:
16236875
[PubMed - indexed for MEDLINE]
10.

Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism.

Bhutia S, Wong PF.

Cochrane Database Syst Rev. 2013 Jul 16;7:CD003074. doi: 10.1002/14651858.CD003074.pub3. Review.

PMID:
23857562
[PubMed - indexed for MEDLINE]
11.

Selecting an anticoagulant for recurrent venous thromboembolism in cancer.

Goodin S.

Am J Health Syst Pharm. 2005 Nov 15;62(22 Suppl 5):S10-3.

PMID:
16286363
[PubMed - indexed for MEDLINE]
12.

Once versus twice daily LMWH for the initial treatment of venous thromboembolism.

van Dongen CJ, Mac Gillavry MR, Prins MH.

Cochrane Database Syst Rev. 2003;(1):CD003074. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003074.

PMID:
12535452
[PubMed - indexed for MEDLINE]
13.

Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection.

Wells PS, Kovacs MJ, Bormanis J, Forgie MA, Goudie D, Morrow B, Kovacs J.

Arch Intern Med. 1998 Sep 14;158(16):1809-12.

PMID:
9738611
[PubMed - indexed for MEDLINE]
14.
15.

Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.

Fiessinger JN, Huisman MV, Davidson BL, Bounameaux H, Francis CW, Eriksson H, Lundström T, Berkowitz SD, Nyström P, Thorsén M, Ginsberg JS; THRIVE Treatment Study Investigators.

JAMA. 2005 Feb 9;293(6):681-9.

PMID:
15701909
[PubMed - indexed for MEDLINE]
16.

Once versus twice daily LMWH for the initial treatment of venous thromboembolism.

van Dongen CJ, MacGillavry MR, Prins MH.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003074. Review. Update in: Cochrane Database Syst Rev. 2013;7:CD003074.

PMID:
16034885
[PubMed - indexed for MEDLINE]
17.

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study.

Meyer G, Marjanovic Z, Valcke J, Lorcerie B, Gruel Y, Solal-Celigny P, Le Maignan C, Extra JM, Cottu P, Farge D.

Arch Intern Med. 2002 Aug 12-26;162(15):1729-35.

PMID:
12153376
[PubMed - indexed for MEDLINE]
18.

Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.

[No authors listed]

Prescrire Int. 2013 Apr;22(137):99-101, 103-4. Review.

PMID:
23662321
[PubMed - indexed for MEDLINE]
19.

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.

Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, Gent M; Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators.

N Engl J Med. 2003 Jul 10;349(2):146-53.

PMID:
12853587
[PubMed - indexed for MEDLINE]
Free Article
20.

A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire.

Simonneau G, Sors H, Charbonnier B, Page Y, Laaban JP, Azarian R, Laurent M, Hirsch JL, Ferrari E, Bosson JL, Mottier D, Beau B.

N Engl J Med. 1997 Sep 4;337(10):663-9.

PMID:
9278462
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk